Jonathan Bornstein Kensington Capital Acquisition Corp. Iv (KCAC-UN) insider trading activity

Jonathan Bornstein is President of Amprius Lab of Kensington Capital Acquisition Corp. IV. Currently has a direct ownership of 454,131 shares of KCAC-UN, which is worth approximately $0. The most recent transaction as insider was on Nov 21, 2024, when has been sold 18,170 shares (Common Stock) at a price of $1.96 per share, resulting in proceeds of $35,613. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 454K

70.28% 3M change

Infinity% 12M change

Total Value Held $0

Jonathan Bornstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2024	SELL Open market or private sale	$35,613 $1.96 p/Share	18,170 Reduced 3.85%	454,131 Common Stock
Aug 21 2024	SELL Open market or private sale	$19,389 $1.04 p/Share	18,644 Reduced 1.21%	1,528,251 Common Stock
May 22 2024	SELL Open market or private sale	$11,874 $1.36 p/Share	8,731 Reduced 0.56%	1,546,895 Common Stock
May 21 2024	SELL Open market or private sale	$14,857 $1.33 p/Share	11,171 Reduced 0.71%	1,555,626 Common Stock
Apr 12 2024	BUY Exercise of conversion of derivative security	$50,393 $0.05 p/Share	1,007,867 Added 39.15%	1,566,797 Common Stock
Apr 02 2024	SELL Open market or private sale	$299,839 $2.38 p/Share	125,983 Reduced 18.39%	558,930 Common Stock
Apr 02 2024	BUY Exercise of conversion of derivative security	$6,299 $0.05 p/Share	125,983 Added 15.54%	684,913 Common Stock
Mar 19 2024	BUY Grant, award, or other acquisition	-	558,930 Added 50.0%	558,930 Common Stock
Mar 06 2024	SELL Open market or private sale	$111,755 $2.78 p/Share	40,200 Reduced 100.0%	0 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	$2,010 $0.05 p/Share	40,200 Added 50.0%	40,200 Common Stock
Mar 05 2024	SELL Open market or private sale	$320,616 $2.92 p/Share	109,800 Reduced 100.0%	0 Common Stock
Mar 05 2024	BUY Exercise of conversion of derivative security	$5,490 $0.05 p/Share	109,800 Added 50.0%	109,800 Common Stock
Feb 06 2024	SELL Open market or private sale	$664,500 $4.43 p/Share	150,000 Reduced 100.0%	0 Common Stock
Feb 06 2024	BUY Exercise of conversion of derivative security	$7,500 $0.05 p/Share	150,000 Added 50.0%	150,000 Common Stock
Jan 02 2024	SELL Open market or private sale	$703,500 $4.69 p/Share	150,000 Reduced 100.0%	0 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$7,500 $0.05 p/Share	150,000 Added 50.0%	150,000 Common Stock
Dec 07 2023	SELL Open market or private sale	$211,370 $3.88 p/Share	54,477 Reduced 100.0%	0 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$2,723 $0.05 p/Share	54,477 Added 50.0%	54,477 Common Stock
Dec 06 2023	SELL Open market or private sale	$192,023 $4.02 p/Share	47,767 Reduced 100.0%	0 Common Stock
Dec 06 2023	BUY Exercise of conversion of derivative security	$2,388 $0.05 p/Share	47,767 Added 50.0%	47,767 Common Stock
Dec 05 2023	SELL Open market or private sale	$204,395 $4.28 p/Share	47,756 Reduced 100.0%	0 Common Stock
Dec 05 2023	BUY Exercise of conversion of derivative security	$2,387 $0.05 p/Share	47,756 Added 50.0%	47,756 Common Stock
Nov 20 2023	SELL Open market or private sale	$106,103 $3.84 p/Share	27,631 Reduced 100.0%	0 Common Stock
Nov 20 2023	BUY Exercise of conversion of derivative security	$1,381 $0.05 p/Share	27,631 Added 50.0%	27,631 Common Stock
Nov 09 2023	SELL Open market or private sale	$139,612 $2.82 p/Share	49,508 Reduced 100.0%	0 Common Stock

Jonathan Bornstein

President of Amprius Lab

Fremont, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KCAC-UN shares.

Notify only if

Value

Insider Trading

Get notified when an Kensington Capital Acquisition Corp. Iv insider buys or sells KCAC-UN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kensington Capital Acquisition Corp. IV

Track Activities on KCAC-UN

Account